Nitika Paudel, MD.PhD

Radiation Oncologist @Lombardicancer. Trained @northwesternmed | Kathmandu🇳🇵➡️ New Jersey ➡️Chicago ➡️ D.C

[Nitika Paudel, MD.PhD @NitikaPaudel]

@StephenVLiu @LombardiCancer @Joshua_Reuss @chulkimMD Feel fortunate to work w and learn from the A team 🙏

[Stephen V Liu, MD @StephenVLiu]

One day away! Join us in downtown Washington, DC Saturday Oct 4th, 8am, for the DC Lung Cancer Conference, an @IASLC endorsed, 1-day CME meeting covering updates in lung cancer, featuring 58 thoughtful & dynamic faculty members! #DCLung25

Registration on site available!

[Stephen V Liu, MD @StephenVLiu]

Be sure to attend #DCLung25 - Saturday, October 4th in Washington DC: a one-day @IASLC endorsed lung cancer conference with experts like radiation oncologist Dr. Nitika Paudel @NitikaPaudel, who will discuss treating unresectable NSCLC. Register today!

https://t.co/OJz1a1lAHb

[Stephen V Liu, MD @StephenVLiu]

#ASTRO24 First @ASTRO_org meeting for me - impressed by the science, the setup, and the community. Hope to see you next year in SF! @NitikaPaudel @KHigginsMD @SalmaJabbour1 @JeffBradleyMD @PercyLeeMD @JoeChangMD Qunyh Nguyen

[Tamer Refaat, MD PhD MSCI @TamerRefaatMD]

Whether in the conference hallways or at planned dinners, #ASTRO24 is the perfect place to reconnect with beloved friends and colleagues. Grateful for these moments! #RadOnc

[Nitika Paudel, MD.PhD @NitikaPaudel]

@SbrtSean He’s the best !

[Nitika Paudel, MD.PhD @NitikaPaudel]

@chulkimMD @LombardiCancer ❤️ our team

[Chul Kim @chulkimMD]

Took a photo of our multidisciplinary clinic team for yesterday’s session to share with first graders tomorrow for Career Day.

Teamwork makes the dream work!

@LombardiCancer

[Georgetown Radiation Oncology Residency @MGUHRadOnc]

Incredibly grateful to be visited by two giants in the field of thoracic oncology, @_ShankarSiva and @StephenVLiu, and hear their ideas on how to advance lung cancer treatment!

#fightcancer #radiationoncology #radonc #oncology #medstar #lungcancer #georgetown #cyberknife

[Nitika Paudel, MD.PhD @NitikaPaudel]

@FordePatrick Thank you. We had the best session :-)

[Nitika Paudel, MD.PhD @NitikaPaudel]

The most fun pre-conference night every time! #DCLung23

[Stephen V Liu, MD @StephenVLiu]

Out with the #DCLung23 faculty throwing some axes! @jillfeldman4 @NitikaPaudel @NarjustFlorezMD @jennifermarksmd @ElaineShumMD @BrendonStilesMD @DoctorJSpicer @DrewMoghanaki @ryangentzler @LealTiciana @SusanScottMD @chulkimMD @Joshua_Reuss @benlevylungdoc @DrSteveMartin

[Nitika Paudel, MD.PhD @NitikaPaudel]

@StephenVLiu Thanks for the invitation. What a great meeting !

[Nitika Paudel, MD.PhD @NitikaPaudel]

Can’t wait for this !!

[Stephen V Liu, MD @StephenVLiu]

This Saturday - join us in downtown DC for #DCLung23 to hear TWO debates: @BrendonStilesMD & @DrewMoghanaki discuss sublobar resection vs SBRT for stage I ineligible for lobectomy and @SusanScottMD & @Joshua_Reuss debate whether STK11/KEAP1 should influence 1L therapy in NSCLC.

[Stephen V Liu, MD @StephenVLiu]

Plan your trip to Washington, DC on Saturday, October 7, 2023 for a 1-day, @IASLC endorsed, #CME/#MOC lung cancer conference. Get completely brought up to speed with an amazing, engaging faculty roster! Registration for #DCLung23 is open! #LCSM

https://t.co/ffoN76B9kD

[Nitika Paudel, MD.PhD @NitikaPaudel]

@chulkimMD Can they come to ILC as therapy kittens?

[Nitika Paudel, MD.PhD @NitikaPaudel]

Much needed study in the space of SBRT and IO for early stage NSCLC. Congratulations @JoeChangMD and MD Anderson team .

[Joe Y Chang @JoeChangMD]

Randomized study published in Lancet today, showing 62% EFS improvement with Nivo + SABR compared with SABR alone in early stage NSCLC. I-SABR is a promising TX option.

awbs://authors.elsevier.com/c/1hRV5V-4XL3dJ
@IASLC
@MDAndersonNews @TheLancet @ACKoongMDPhD
@StephenVLiu

[Nitika Paudel, MD.PhD @NitikaPaudel]

@StephenVLiu @BrendonStilesMD @DrewMoghanaki @IASLC I’m beyond excited for this 🤓

[Nitika Paudel, MD.PhD @NitikaPaudel]

@chulkimMD Congratulations!

[Nitika Paudel, MD.PhD @NitikaPaudel]

I share this experience and frustration as well. So much time, effort and resources spent on prior auth. #fixpriorauth

[Jeff Ryckman @jryckman3]

Despite the substantially less financial burden of #radonc healthcare services, the #priorauth burden falls disproportionately on our #costeffective specialty.

Many patients I treat will have a built-in two-week delay before simulation due to #priorauth #fixpriorauth

In my first three years of practice, I am batting 1.000 on insurance rebuttals. What is the point of prior authorization if everything intended by the physician gets approved anyway? Is the goal to delay care for cancer patients? If so, the #priorauth is a resounding success. #thisisamerica

Measuring the scope of prior authorization policies: https://t.co/vbtzYn7esw

#priorauth may drive racial disparities: https://t.co/dkILKwYlnF HT @DrHut10

[Nitika Paudel, MD.PhD @NitikaPaudel]

@SbrtSean Congratulations!